Summary
Amgen Inc. (AMGN) filed an 8-K report on May 22, 2017, detailing outcomes from its Annual Meeting held on May 19, 2017, and a key executive change. The company announced the appointment of Annette L. Such as Vice President and Chief Audit Executive, effective with the second quarter 2017 Form 10-Q filing. Upon this transition, Ms. Such will step down as Chief Accounting Officer, and CFO David W. Meline will assume the role of principal accounting officer until a new CAO is appointed. This change in accounting oversight is a noteworthy operational update for investors to monitor. The Annual Meeting saw all 13 director nominees elected to serve one-year terms, reflecting strong shareholder confidence in the board's composition. Shareholders also ratified Ernst & Young LLP as the independent registered public accountants for the fiscal year ending December 31, 2017. Furthermore, the "say-on-pay" advisory vote to approve executive compensation was approved, and shareholders determined that this vote should occur annually. A significant outcome was the rejection of a stockholder proposal to adopt a majority votes cast standard for matters presented by stockholders.
Key Highlights
- 1Annette L. Such appointed Vice President and Chief Audit Executive, effective with the Q2 2017 10-Q filing.
- 2Current Chief Accounting Officer Annette L. Such will step down from her CAO role upon the Q2 2017 10-Q filing.
- 3CFO David W. Meline will serve as principal accounting officer until a new Chief Accounting Officer is appointed.
- 4All 13 director nominees were elected for one-year terms.
- 5Ernst & Young LLP ratified as the independent registered public accountants for the fiscal year ending December 31, 2017.
- 6Shareholders approved the advisory vote on executive compensation ('say-on-pay').
- 7Shareholders voted to hold the advisory vote on executive compensation annually.